Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita

Epidermolysis bullosa acquisita (EBA) is a rare, but prototypical, organ-specific autoimmune disease, characterized and caused by autoantibodies against type VII collagen (COL7). Mucocutaneous inflammation, blistering, and scarring are the clinical hallmarks of the disease. Treatment of EBA is diffi...

Descripción completa

Detalles Bibliográficos
Autores principales: Koga, Hiroshi, Kasprick, Anika, López, Rosa, Aulí, Mariona, Pont, Mercè, Godessart, Núria, Zillikens, Detlef, Bieber, Katja, Ludwig, Ralf J., Balagué, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052048/
https://www.ncbi.nlm.nih.gov/pubmed/30050528
http://dx.doi.org/10.3389/fimmu.2018.01558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052048/
https://www.ncbi.nlm.nih.gov/pubmed/30050528
http://dx.doi.org/10.3389/fimmu.2018.01558

Ejemplares similares